Tumor metabolism regulates cellular function, energy homeostasis, and therapeutic response. Dysregulated bioenergetics can influence drug efficacy and resistance, making quantitative metabolic profiling essential for translational oncology research.
QSM™ quantifies activity across 22 key metabolic pathways, including ATP production, glycolysis, OXPHOS, and mitochondrial respiration. Integration with proteomic analysis captures enzyme activities and regulatory features, providing systems-level insight into tumor bioenergetics.
Scalable analysis, including scarce or FFPE clinical samples, links metabolic profiles to pharmacodynamic responses. These data support early candidate prioritization, patient-relevant stratification, and mechanism-driven therapy optimization, enhancing preclinical-to-clinical predictivity.
Main Benefit
Provide actionable, systems-level metabolic insights that inform candidate prioritization, patient stratification, and translational decision-making in cancer drug development.
